Picture of Enliven Therapeutics logo

ELVN — Enliven Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Imara Inc expected to post a loss of 20 cents a share - Earnings Preview

* Imara Inc  IMRA.OQ   IMRA.O  is expected to report 
results on
November 7 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Imara Inc is for a
loss
of 20 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts had risen by
about 30.7%
in the last three months. ​
    * Wall Street's median 12-month price target for Imara Inc
is
$1.4​, below​ its last closing price of $4.22. ​​​

This summary was machine generated November 4 at 14:32 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Enliven Therapeutics

See all news